2011
DOI: 10.1590/s1516-89132011000200010
|View full text |Cite
|
Sign up to set email alerts
|

Formulation and characterization of gastroretentive discs containing famotidine

Abstract: In this work a different type of formulation, as disc, containing a selected mucoadhesive polymer, fillers, and binders were investigated for their potential as a mucoadhesive gastroretentive delivery system to deliver famotidine in the stomach. Various types of hydrophilic diluents were evaluated for their swelling and mucoadhesive property and one (polyvinylpyrrolidone, PVP) was selected to combine with the selected mucoadhesive polymer (polyethylene oxide, PEO). Discs with different ratios of PEO and PVP we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 29 publications
0
5
0
Order By: Relevance
“…As thiolated formulations will form strong disulfide bonds with mucus, accordingly maximum force is required for the detachment from the mucus. Both residence time and mucoadhesion strength were increased accordingly with the concentrations of TOG in RGM-5 and RGM-6 due to high -SH content which favors the number of disulfide bonds with the mucus gel layer [41]. Formulations with SA showed moderate mucoadhesion time and strength.…”
Section: Evaluation Of Ex-vivo Mucoadhesion Time and Mucoadhesion Strmentioning
confidence: 99%
“…As thiolated formulations will form strong disulfide bonds with mucus, accordingly maximum force is required for the detachment from the mucus. Both residence time and mucoadhesion strength were increased accordingly with the concentrations of TOG in RGM-5 and RGM-6 due to high -SH content which favors the number of disulfide bonds with the mucus gel layer [41]. Formulations with SA showed moderate mucoadhesion time and strength.…”
Section: Evaluation Of Ex-vivo Mucoadhesion Time and Mucoadhesion Strmentioning
confidence: 99%
“…This property can further increase its residence time in the stomach. This mucoadhesive force is less than that detected in the formulation with one of the most frequently used hydrophilic polymers [13,41]. On the other hand, the PEG content of our formulation may contribute to a prolonged gastric residence time.…”
Section: Discussionmentioning
confidence: 64%
“…In vivo gastroretentive study was performed to confirm the retention of the BaSO 4 -loaded samples in the stomach, for the suitability of the technology for drug development. BaSO 4 is a contrast agent that is used in clinical imaging area with high-density and high X-ray absorbing properties which make it suitable to determine the intracorporeal location of the compositions [23,24].…”
Section: In Vivo Gastroretentive Studymentioning
confidence: 99%
“…BaSO 4 is a contrast agent that is used in clinical imaging area with high-density and high X-ray absorbing properties which make it suitable to determine the intracorporeal location of the compositions [23,24]. Figure 8 (a) shows that the formulation appeared in a well-defined way in the stomach 30 min after the administration.…”
Section: In Vivo Gastroretentive Studymentioning
confidence: 99%